Opportunity ID: |
329611 |
Opportunity Number: |
FOR-FD-20-25 |
Opportunity Title: |
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership |
Opportunity Category: |
Discretionary |
Opportunity Category Explanation: |
|
Funding Instrument Type: |
Cooperative Agreement |
Category of Funding Activity: |
Agriculture Consumer Protection Science and Technology and other Research and Development |
Category Explanation: |
|
CFDA Number(s): |
93.103 |
Eligible Applicants: |
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses |
Additional Information on Eligibility: |
|
Agency Code: |
HHS-FDA |
Agency Name: |
Department of Health and Human Services Food and Drug Administration |
Posted Date: |
Oct 28, 2020 |
Last Updated Date: |
Oct 28, 2020 |
Estimated Synopsis Post Date: |
|
Fiscal Year: |
2021 |
Award Ceiling: |
|
Award Floor: |
|
Estimated Total Program Funding: |
|
Expected Number of Awards: |
|
Description: |
Millions of children receive anesthetic and sedation drugs each year for surgical and non-surgical procedures. Over the past two decades, an expanding body of data from animal studies have demonstrated that exposure of the developing brain to anesthetic and sedation agents is associated with neurodegeneration and long-term, likely permanent, deficits in cognitive function and behavior. Under the Critical Path Initiative, SmartTots Public-Private Partnership (PPP) was established to address the critical public health issues associated with the safe use of anesthetic agents and sedatives in young children. The objective of this cooperative agreement is to continue bridging the knowledge gaps, elucidating the risks related to the use of anesthetic and sedative agents in children, and developing strategies for optimizing brain health in children who require anesthesia and sedation care. |
Version: |
1 |